Skip to main content
Top
Published in: International Journal of Hematology 3/2009

01-10-2009 | Case Report

Successful allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by severe pulmonary alveolar proteinosis

Authors: Sumie Tabata, Sonoko Shimoji, Kimihiko Murase, Yoko Takiuchi, Daichi Inoue, Takaharu Kimura, Yuya Nagai, Minako Mori, Katsuhiro Togami, Masayuki Kurata, Kiminari Ito, Hisako Hashimoto, Akiko Matushita, Kenichi Nagai, Takayuki Takahashi

Published in: International Journal of Hematology | Issue 3/2009

Login to get access

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare disorder characterized by the abnormal accumulation of alveolar surfactant protein in alveolar spaces. We report herein a rare case of myelodysplastic syndrome (MDS-RAEB) complicated by severe PAP, and successful allogeneic bone marrow transplantation (BMT) for both disorders. An unrelated BMT was planned for a 48-year-old male with advanced MDS-RAEB. Just before the initiation of the conditioning regimen for unrelated BMT in March 2007, he developed dyspnea. A diagnosis of PAP was made based on findings of chest X-ray, CT scanning, and the fluid obtained by bronchoalveolar lavage. To improve his dyspnea and improve BMT safety, whole lung lavage (WLL) was performed twice, with the partial improvement of PAP. Unrelated allogeneic BMT was performed in September 2007. We had to perform a third WLL because of the worsening of PAP on day 26 after BMT. Despite many infectious complications after BMT, GVHD was relatively mild. PAP had almost disappeared 6 months after BMT. He was well with favorable hematopoiesis 20 months after the BMT without any specific treatment. There has been no report of an MDS patient with PAP in whom 3 WLL procedures were performed before and after allogeneic BMT.
Literature
1.
go back to reference Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. New Engl J Med. 1958;258:1123–42.CrossRefPubMed Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. New Engl J Med. 1958;258:1123–42.CrossRefPubMed
2.
go back to reference Locachimescu OC, Kavuru MS. Pulmonary alveolar proteinosis. Chronic Respir Dis. 2006;3:149–59.CrossRef Locachimescu OC, Kavuru MS. Pulmonary alveolar proteinosis. Chronic Respir Dis. 2006;3:149–59.CrossRef
3.
go back to reference Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, Bronson RT, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science. 1994;264:713–6.CrossRefPubMed Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, Bronson RT, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science. 1994;264:713–6.CrossRefPubMed
4.
go back to reference Ikegami M, Ueda T, Hull W, Whitsett JA, Mulligan RC, Dranoff G, et al. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am J Physiol. 1996;270:L650–8.CrossRefPubMed Ikegami M, Ueda T, Hull W, Whitsett JA, Mulligan RC, Dranoff G, et al. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am J Physiol. 1996;270:L650–8.CrossRefPubMed
5.
go back to reference Kitamura T, Tanaka N, Watanabe J, Uchida K, Kanegasaki S, Yamada Y, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med. 1999;190:875–80.CrossRefPubMedPubMedCentral Kitamura T, Tanaka N, Watanabe J, Uchida K, Kanegasaki S, Yamada Y, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med. 1999;190:875–80.CrossRefPubMedPubMedCentral
6.
go back to reference Dirksen U, Nishinakamura R, Groneck P, Hattenhorst U, Nogee L, Murray R, et al. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common β chain expression. J Clin Invest. 1997;100:2211–7.CrossRefPubMedPubMedCentral Dirksen U, Nishinakamura R, Groneck P, Hattenhorst U, Nogee L, Murray R, et al. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common β chain expression. J Clin Invest. 1997;100:2211–7.CrossRefPubMedPubMedCentral
7.
go back to reference Cordonnier C, Fleury-Feith J, Escudier E, Atassi K, Bernaudin JF. Secondery alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med. 1994;149:788–94.CrossRefPubMed Cordonnier C, Fleury-Feith J, Escudier E, Atassi K, Bernaudin JF. Secondery alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med. 1994;149:788–94.CrossRefPubMed
8.
go back to reference Johkoh T, Itoh H, Muller NL, Ichikado K, Nakamura H, Ikezoe J, et al. Crazy-paving appearance at thin-section CT:spectrum of disease and pathologic findings. Radiology. 1999;211:155–60.CrossRefPubMed Johkoh T, Itoh H, Muller NL, Ichikado K, Nakamura H, Ikezoe J, et al. Crazy-paving appearance at thin-section CT:spectrum of disease and pathologic findings. Radiology. 1999;211:155–60.CrossRefPubMed
9.
go back to reference Prakash UBS, Barham SS, Carpenter HA, Dines DE, Marsh HM. Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc. 1987;62:499–518.CrossRefPubMed Prakash UBS, Barham SS, Carpenter HA, Dines DE, Marsh HM. Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc. 1987;62:499–518.CrossRefPubMed
10.
go back to reference John FS, Jeffrey JP. Pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2002;166:215–35.CrossRef John FS, Jeffrey JP. Pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2002;166:215–35.CrossRef
11.
go back to reference Tazawa R, Hamano E, Arai T, Ohta H, Ishimoto O, Uchida K, et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Resir Crit Care Med. 2005;171:1142–9.CrossRef Tazawa R, Hamano E, Arai T, Ohta H, Ishimoto O, Uchida K, et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Resir Crit Care Med. 2005;171:1142–9.CrossRef
12.
go back to reference Tomonari A, Shirafuji N, Iseki N, Ooi J, Nagayama H, Masunaga A, et al. Acquired pulmonary alveolar proteinosis after umbilical cord blood transplantation for acute myeloid leukemia. Am J Hemato. 2002;70:154–7.CrossRef Tomonari A, Shirafuji N, Iseki N, Ooi J, Nagayama H, Masunaga A, et al. Acquired pulmonary alveolar proteinosis after umbilical cord blood transplantation for acute myeloid leukemia. Am J Hemato. 2002;70:154–7.CrossRef
13.
go back to reference Butnor KJ, Sporn TA. Human parainfluenza virus giant cell pneumonia following cord blood transplant associated with pulmonary alveolar proteinosis. Arch Pathol Lab Med. 2003;127:235–8.PubMed Butnor KJ, Sporn TA. Human parainfluenza virus giant cell pneumonia following cord blood transplant associated with pulmonary alveolar proteinosis. Arch Pathol Lab Med. 2003;127:235–8.PubMed
14.
go back to reference Dirksen U, Hattenhorst U, Schneider P, Schroten H, Gobel U, Bocking, et al. Defective expression of granulocyte macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common β chain in children with acute myeloid leukemia associated with respiratory failure. Blood. 1998;92:1097–103.PubMed Dirksen U, Hattenhorst U, Schneider P, Schroten H, Gobel U, Bocking, et al. Defective expression of granulocyte macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common β chain in children with acute myeloid leukemia associated with respiratory failure. Blood. 1998;92:1097–103.PubMed
15.
go back to reference Numata A, Matsuishi E, Koyanogi K, Saito S, Miyamoto Y, Irie K, et al. Successful therapy with whole-lung lavage and autologous peripheral blood stem cell transplantation for pulmonary alveolar proteinosis complicating acute myelogenous leukemia. Am J Hematol. 2006;81:107–9.CrossRefPubMed Numata A, Matsuishi E, Koyanogi K, Saito S, Miyamoto Y, Irie K, et al. Successful therapy with whole-lung lavage and autologous peripheral blood stem cell transplantation for pulmonary alveolar proteinosis complicating acute myelogenous leukemia. Am J Hematol. 2006;81:107–9.CrossRefPubMed
16.
go back to reference Rodriguez-Luaces M, Lafuente A, Martin MP, Mateos P, Ojeda E, Hernandez-Navarro F. Haematopoietic transplantation in pulmonary alveolar proteinosis associated with chronic myelogenous leukemia. Bone Marrow Transplant. 1997;20:507–10.CrossRefPubMed Rodriguez-Luaces M, Lafuente A, Martin MP, Mateos P, Ojeda E, Hernandez-Navarro F. Haematopoietic transplantation in pulmonary alveolar proteinosis associated with chronic myelogenous leukemia. Bone Marrow Transplant. 1997;20:507–10.CrossRefPubMed
17.
go back to reference Fukuno K, Tomonari A, Tsukada N, Takahashi S, Ooi J, Konuma T, et al. Successful cord blood transplantation for myelodysplastic syndrome resulting in resolution of pulmonary alveolar proteinosis. Bone Marrow Transplant. 2006;38:581–581.CrossRefPubMed Fukuno K, Tomonari A, Tsukada N, Takahashi S, Ooi J, Konuma T, et al. Successful cord blood transplantation for myelodysplastic syndrome resulting in resolution of pulmonary alveolar proteinosis. Bone Marrow Transplant. 2006;38:581–581.CrossRefPubMed
18.
go back to reference Chan ED, King TE. Pulmonary alveolar proteinosis. Up to date. MA: Waitham; 2009. Chan ED, King TE. Pulmonary alveolar proteinosis. Up to date. MA: Waitham; 2009.
Metadata
Title
Successful allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by severe pulmonary alveolar proteinosis
Authors
Sumie Tabata
Sonoko Shimoji
Kimihiko Murase
Yoko Takiuchi
Daichi Inoue
Takaharu Kimura
Yuya Nagai
Minako Mori
Katsuhiro Togami
Masayuki Kurata
Kiminari Ito
Hisako Hashimoto
Akiko Matushita
Kenichi Nagai
Takayuki Takahashi
Publication date
01-10-2009
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2009
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-009-0404-4

Other articles of this Issue 3/2009

International Journal of Hematology 3/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine